Inactive Instrument
4Front Ventures Corp. Share Price Canadian Securities Exchange
Equities
FFNT
CA35086B2075
Healthcare Facilities & Services
| Capitalization | 12.36M 10.66M 9.62M 9.22M 16.76M 1.14B 17.53M 114M 45.57M 544M 46.38M 45.38M 1.95B | P/E ratio 2022 |
-3.15x | P/E ratio 2023 | -0.7x |
|---|---|---|---|---|---|
| Enterprise value | 235M 203M 183M 175M 319M 21.63B 333M 2.16B 866M 10.35B 881M 862M 37.13B | EV / Sales 2022 |
3.17x | EV / Sales 2023 | 2.97x |
| Free-Float |
48.93% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Thut
CEO | Chief Executive Officer | 53 | 07/01/2024 |
Karl Chowscano
DFI | Director of Finance/CFO | - | - |
| General Counsel | - | 08/06/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 916 | |
| +1.28% | +4.81% | +35.17% | -45.56% | 195M | |
| 0.00% | 0.00% | +41.54% | +119.05% | 134M | |
| 0.00% | +7.69% | +89.83% | -54.84% | 113M | |
| -1.78% | +4.49% | +81.89% | -18.49% | 99.85M | |
| Average | -0.36% | +3.66% | +62.11% | +0.04% | 135.58M | |
| Weighted average by Cap. | -0.33% | +2.81% | +56.76% | -1.85% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 119M 102M 92.37M 88.52M 161M 10.92B 168M 1.09B 437M 5.23B 445M 436M 18.75B | 97.44M 84.05M 75.9M 72.74M 132M 8.98B 138M 896M 359M 4.29B 366M 358M 15.41B |
| Net income | -46.9M -40.45M -36.53M -35.01M -63.63M -4.32B -66.53M -431M -173M -2.07B -176M -172M -7.42B | -91.65M -79.05M -71.39M -68.42M -124M -8.44B -130M -843M -338M -4.04B -344M -337M -14.49B |
| Net Debt | 226M 195M 176M 168M 306M 20.79B 320M 2.08B 832M 9.94B 847M 829M 35.68B | 222M 192M 173M 166M 302M 20.49B 316M 2.05B 820M 9.8B 835M 817M 35.18B |
Employees
387
